Acciones Biotie Therapies Corp

Acciones

Diferido Nasdaq Helsinki Otros sitios de cotización			Varia. Cinco días.	Varia. 1 de enero.
- ^EUR	-.--%		-.--%	-.--%

Duración

Período

Estilo

Biotie Therapies : ACORDA GAINS TITLE TO BIOTIE SHARES AND THE SHARES WILL DELIST	30/09/16
Biotie Therapies : ARBITRAL TRIBUNAL CONFIRMED ACORDA'S REDEMPTION RIGHT REGARDING BIOTIE SHARES AND BIOTIE SHARES TRADING HAS BEEN TERMINATED	26/09/16
Biotie: BTT1023 receives Orphan Drug Designation in the United States	26/08/16
Biotie Therapies : THE LISTING COMMITTEE OF NASDAQ HELSINKI HAS RESOLVED TO DELIST THE SHARES OF BIOTIE THERAPIES CORP.	25/08/16
Biotie Therapies : CORP. APPLIES FOR DELISTING OF ITS SHARES FROM NASDAQ HELSINKI	18/08/16

Directores	Puesto	Edad	Desde
Antero Kallio CEO	Chief Executive Officer	64	01/06/05

Administradores	Puesto	Edad	Desde
Ronald Cohen CHM	Chairman	68	01/05/16
Jane Wasman BRD	Director/Board Member	67	01/05/16
Andrew Hindman BRD	Director/Board Member	51	01/12/16

Sector

	Varia. 1 de ene.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31 %	103 mil M
REGENERON PHARMACEUTICALS, INC.	+0,56 %	95,28 mil M
ARGENX SE	+1,69 %	22,15 mil M
BIONTECH SE	-17,37 %	21,02 mil M
GENMAB A/S	-9,30 %	18,15 mil M
WUXI APPTEC CO., LTD.	-41,01 %	16,74 mil M
BEIGENE, LTD.	-14,85 %	16,05 mil M
NEUROCRINE BIOSCIENCES, INC.	+3,21 %	13,68 mil M
SAREPTA THERAPEUTICS, INC.	+33,54 %	12,17 mil M